Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey R Curtis

Showing results (1-10 of 639) with videos related to

Pageof 64
Sort By:
Arthritis Care & Research|April 24, 2014
Reply: To PMID 22504829Jeffrey R Curtis
Current Opinion in Rheumatology|May 23, 2019
The promise and perils of 'Big Data': focus on spondyloarthritisJeffrey R Curtis
Drug Safety|February 3, 2018
Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for CliniciansAprajita Jagpal, Jeffrey R Curtis
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2023
The Art of Communicating Risk and Benefit to Promote Shared Decision-Making, Informed by Behavioral Economic PrinciplesJeffrey R Curtis, Liana Fraenkel
Current Opinion in Rheumatology|March 27, 2014
Considerations in using registry and health plan data for studying pregnancy in rheumatic diseasesJie Zhang, Jeffrey R Curtis
Current Rheumatology Reports|September 27, 2008
Tumor necrosis factor inhibitors and infection complicationsMonica Crawford, Jeffrey R Curtis
Current Opinion in Rheumatology|March 20, 2013
New methods for determining comparative effectiveness in rheumatoid arthritisHuifeng Yun, Jeffrey R Curtis
JMIR Mhealth and Uhealth|April 11, 2023
Uptake of Remote Physiologic Monitoring in the US Medicare Program: A Serial Cross-sectional AnalysisJeffrey R Curtis, James Willig
Clinical Therapeutics|June 28, 2011
Use of biologics in rheumatoid arthritis: current and emerging paradigms of careJeffrey R Curtis, Jasvinder A Singh
Current Opinion in Rheumatology|March 21, 2013
Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid arthritisIris Navarro-Millán, Jeffrey R Curtis
Pageof 64

Showing results (1-10 of 639) with videos related to

Sort By:
Pageof 64
Arthritis Care & Research|April 24, 2014
Reply: To PMID 22504829Jeffrey R Curtis
Current Opinion in Rheumatology|May 23, 2019
The promise and perils of 'Big Data': focus on spondyloarthritisJeffrey R Curtis
Drug Safety|February 3, 2018
Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for CliniciansAprajita Jagpal, Jeffrey R Curtis
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2023
The Art of Communicating Risk and Benefit to Promote Shared Decision-Making, Informed by Behavioral Economic PrinciplesJeffrey R Curtis, Liana Fraenkel
Current Opinion in Rheumatology|March 27, 2014
Considerations in using registry and health plan data for studying pregnancy in rheumatic diseasesJie Zhang, Jeffrey R Curtis
Current Rheumatology Reports|September 27, 2008
Tumor necrosis factor inhibitors and infection complicationsMonica Crawford, Jeffrey R Curtis
Current Opinion in Rheumatology|March 20, 2013
New methods for determining comparative effectiveness in rheumatoid arthritisHuifeng Yun, Jeffrey R Curtis
JMIR Mhealth and Uhealth|April 11, 2023
Uptake of Remote Physiologic Monitoring in the US Medicare Program: A Serial Cross-sectional AnalysisJeffrey R Curtis, James Willig
Clinical Therapeutics|June 28, 2011
Use of biologics in rheumatoid arthritis: current and emerging paradigms of careJeffrey R Curtis, Jasvinder A Singh
Current Opinion in Rheumatology|March 21, 2013
Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid arthritisIris Navarro-Millán, Jeffrey R Curtis
Pageof 64